 "coronavirus drug, pharma")
Goa's Health Ministry on Friday received 1,008 vials of Remdesivir from pharma major Cipla. Remdesivir is an anti-viral drug which is administered to Covid-19 patients and results in faster recovery, state Health Minister Vishwajit Rane said.
"This anti-viral drug will be beneficial in suppressing the viral replication of SARS-CoV-2, the coronavirus that causes COVID-19. Uncontrollable viral replication is often responsible for tissue damage and deaths in patients infected with the virus," Rane said in a statement.
The minister also said that the anti-viral drug will be administered to moderately and severely-ill patients suffering from COVID-19 and would help to suppress the viral replication of SARS-CoV-2.
"The drug will help in faster recovery of COVID-19 patients. Introduction of Remdesivir in the COVID-19 treatment protocol will also help us reduce COVID-19 deaths associated with co-morbidity," Rane said.
Goa is currently witnessing a sustained spike in the number of Covid-19 cases. The state has recorded 7,614 coronavirus cases in all, out of which 2,095 are active. 66 people have died after contracting the deadly infection.
--IANS
maya/kr
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
